ZA895869B - Quinoline and pyridine anchors for hmg-coa reductase inhibitors - Google Patents

Quinoline and pyridine anchors for hmg-coa reductase inhibitors

Info

Publication number
ZA895869B
ZA895869B ZA895869A ZA895869A ZA895869B ZA 895869 B ZA895869 B ZA 895869B ZA 895869 A ZA895869 A ZA 895869A ZA 895869 A ZA895869 A ZA 895869A ZA 895869 B ZA895869 B ZA 895869B
Authority
ZA
South Africa
Prior art keywords
hmg
anchors
quinoline
pyridine
coa reductase
Prior art date
Application number
ZA895869A
Inventor
Jeffrey Adam Robl
Adam Robl Jeffrey
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of ZA895869B publication Critical patent/ZA895869B/en

Links

ZA895869A 1988-08-29 1989-08-01 Quinoline and pyridine anchors for hmg-coa reductase inhibitors ZA895869B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23734988A 1988-08-29 1988-08-29

Publications (1)

Publication Number Publication Date
ZA895869B true ZA895869B (en) 1990-05-30

Family

ID=22893355

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895869A ZA895869B (en) 1988-08-29 1989-08-01 Quinoline and pyridine anchors for hmg-coa reductase inhibitors

Country Status (1)

Country Link
ZA (1) ZA895869B (en)

Similar Documents

Publication Publication Date Title
PH25350A (en) PHOSPHOROUS-CONTAINING HMG-CoA REDUCTASE INHIBITORS
JPS6426535A (en) Novel hmg-coa reductase inhibitor
AU6084686A (en) Novel hmg-coa reductase inhibitors
IL134272A0 (en) Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia
IL108075A0 (en) Enzyme inhibitors
ZA925946B (en) Tetrahydroindazole tetrahydrocyclopentapyrazole and hexahydrocycloheptapyrazole compounds and their use as HMG-COA reductase inhibitors
EP0403487A4 (en) Novel hmg-coa reductase inhibitors
PL331339A1 (en) Antihrombotic and antiarteriosclerotic pharmaceutical composition containing derivative of thiene pyridine as well as an inhibitor of hmg-coa reductase
GB2205838B (en) Phosphorus-containing hmg-coa reductase inhibitors
EP0444533A3 (en) Quinoline and pyridine anchors for hmg-coa reductase inhibitors
EP0323866A3 (en) Novel hmg-coa reductase inhibitors
ZA886468B (en) Novel hmg-coa reductase inhibitors
AU637321B2 (en) Quinoline and pyridine anchors for a hmg-coa reductase inhibitors
AU6212398A (en) 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia
EP0415488A3 (en) 7-substituted hmg-coa reductase inhibitors
ZA895869B (en) Quinoline and pyridine anchors for hmg-coa reductase inhibitors
GB9214720D0 (en) Enzyme inhibitors
EP0320052A3 (en) Intermediates and processes for 6-carboxy hmg-coa reductase inhibitors
IE892510L (en) Quinoline and pyridine anchors for hmg-coa reductase¹inhibitors
EP0306263A3 (en) Novel hmg-coa reductase inhibitors
AU4941393A (en) Biosensor for detection of and distinguishing between cholinesterases inhibitors
GB9303051D0 (en) 17b-nmonosubstituted carbamoyl-11-oxo-4-aza-5-a-androst-en-3-one testosterone-5-alpha reductase inhibitors
ZA894895B (en) 5-oxygenated hmg-coa reductase inhibitors
IE822652L (en) HMG-CoA REDUCTASE INHIBITORS
EP0468974A4 (en) Novel hmg-coa reductase inhibitors